Our laboratory studies the molecular basis of hereditary hemorrhagic telangiectasia (HHT), a vascular disease. Successful candidates will develop independent projects to increase our understanding of the molecular pathways leading to HHT. Our laboratory has a track record of identifying disease-modifying interventions (see: JCI 2020, 130(2):942-957; HMG 2017, 26(24):4786-4798) and the candidate who will join our laboratory will contribute to new projects aimed at studying the defective signaling pathways leading to HHT. Ideal candidates will have a publication record that demonstrates an ability to think creatively and who would flourish in an integrated, well-resourced team. A strong background in molecular and cell biology, and prior expertise in mouse handling and confocal microscopy and image analysis are strong plus. Candidates must have a PhD in biology or other relevant fields. Applicants should send a CV, a statement of research interest and experience (up to one page), and 2-3 names of references to email@example.com. More information about the laboratory is available at https://feinstein.northwell.edu/institutes-researchers/our-researchers/philippe-marambaud-phd. Northwell Health is an Affirmative Action/Equal Opportunity employer.